218 related articles for article (PubMed ID: 10632698)
1. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane.
Ferté J
Eur J Biochem; 2000 Jan; 267(2):277-94. PubMed ID: 10632698
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents.
Pérez-Victoria JM; Di Pietro A; Barron D; Ravelo AG; Castanys S; Gamarro F
Curr Drug Targets; 2002 Aug; 3(4):311-33. PubMed ID: 12102602
[TBL] [Abstract][Full Text] [Related]
3. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1).
Sharom FJ
Biochem Cell Biol; 2006 Dec; 84(6):979-92. PubMed ID: 17215884
[TBL] [Abstract][Full Text] [Related]
4. Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP).
Lehne G; Mørkrid L; den Boer M; Rugstad HE
Int J Clin Pharmacol Ther; 2000 Apr; 38(4):187-95. PubMed ID: 10783828
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
Eckford PD; Sharom FJ
Biochemistry; 2008 Dec; 47(51):13686-98. PubMed ID: 19049391
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
Nooter K; Stoter G
Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of P-glycoprotein in relation to passive membrane permeation.
Eytan GD; Kuchel PW
Int Rev Cytol; 1999; 190():175-250. PubMed ID: 10331240
[TBL] [Abstract][Full Text] [Related]
8. Lipids as a target for drugs modulating multidrug resistance of cancer cells.
Hendrich AB; Michalak K
Curr Drug Targets; 2003 Jan; 4(1):23-30. PubMed ID: 12528987
[TBL] [Abstract][Full Text] [Related]
9. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
[TBL] [Abstract][Full Text] [Related]
10. Can long range mechanical interaction between drugs and membrane proteins define the notion of molecular promiscuity? Application to P-glycoprotein-mediated multidrug resistance (MDR).
Rauch C; Paine SW; Littlewood P
Biochim Biophys Acta; 2013 Nov; 1830(11):5112-8. PubMed ID: 23850561
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of a tryptophan-less P-glycoprotein: a tool for tryptophan insertion and fluorescence spectroscopy.
Kwan T; Loughrey H; Brault M; Gruenheid S; Urbatsch IL; Senior AE; Gros P
Mol Pharmacol; 2000 Jul; 58(1):37-47. PubMed ID: 10860925
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance: can different keys open the same lock?
Kaur P
Drug Resist Updat; 2002 Apr; 5(2):61-4. PubMed ID: 12135581
[TBL] [Abstract][Full Text] [Related]
13. ABC transporters in lipid transport.
Borst P; Zelcer N; van Helvoort A
Biochim Biophys Acta; 2000 Jun; 1486(1):128-44. PubMed ID: 10856718
[TBL] [Abstract][Full Text] [Related]
14. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
Guo A; Marinaro W; Hu P; Sinko PJ
Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the P-Glycoprotein Multidrug Transporter with Sterols.
Clay AT; Lu P; Sharom FJ
Biochemistry; 2015 Nov; 54(43):6586-97. PubMed ID: 26484739
[TBL] [Abstract][Full Text] [Related]
16. Lipid regulation of the ABCB1 and ABCG2 multidrug transporters.
Hegedüs C; Telbisz Á; Hegedűs T; Sarkadi B; Özvegy-Laczka C
Adv Cancer Res; 2015; 125():97-137. PubMed ID: 25640268
[TBL] [Abstract][Full Text] [Related]
17. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter.
Romsicki Y; Sharom FJ
Biochemistry; 2001 Jun; 40(23):6937-47. PubMed ID: 11389609
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships.
Di Pietro A; Dayan G; Conseil G; Steinfels E; Krell T; Trompier D; Baubichon-Cortay H; Jault J
Braz J Med Biol Res; 1999 Aug; 32(8):925-39. PubMed ID: 10454753
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia.
van den Heuvel-Eibrink MM; Sonneveld P; Pieters R
Int J Clin Pharmacol Ther; 2000 Mar; 38(3):94-110. PubMed ID: 10739113
[TBL] [Abstract][Full Text] [Related]
20. TNF-α Modulates P-Glycoprotein Expression and Contributes to Cellular Proliferation via Extracellular Vesicles.
Berguetti T; Quintaes LSP; Hancio T; Robaina MC; Cruz ALS; Maia RC; de Souza PS
Cells; 2019 May; 8(5):. PubMed ID: 31137684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
